[1
]
Rossella Elisei, University of Pisa, Pisa; Lisa Licitra, Fondazione Istituto Di Ricovero
e Cura a Carattere Scientifico-Istituto Nazionale dei Tumori, Milan, Italy; Martin
J. Schlumberger, Institut Gustave Roussy, University Paris-Sud, Villejuif, France;
Stefan P. Müller, Universitatsklinikum Essen, Essen; Michael C. Kreissl, Universitätsklinikum
Würzburg, Würzburg, Germany; Patrick Schöffski, University Hospitals Leuven, Leuven,
Belgium; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia,
PA; Manisha H. Shah, Ohio State University Medical Center, Columbus, OH; Barbara Jarzab,
Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie Oddział w Gliwicach, Gliwice,
Poland; Viktor Medvedev, Medical Radiological Research Centre of the Russian Academy
of Medical Sciences, Obninsk, Russia; Bruno Niederle, Medizinische Universität Wien,
Wien, Austria; Ezra E.W. Cohen, University of Chicago, Chicago, IL; Lori J. Wirth,
Massachusetts General Hospital, Boston, MA; Haythem Ali, Henry Ford Health System,
Detroit, MI; Colin Hessel and Yifah Yaron, Exelixis, South San Francisco, CA; Douglas
Ball and Barry Nelkin, Johns Hopkins University School of Medicine, Baltimore, MD;
and Steven I. Sherman, University of Texas MD Anderson Cancer Center, Houston, TX.